This site is intended for UK Healthcare Professionals only

Licensing

rare-1280x720

Major change for rare disease treatments on way, signals MHRA

A new paper from the MHRA sets out UK regulator's intention to overhaul its rulebook for rare disease therapies.

04 Nov 2025

molnupiravir tablets 1280x720.jpg

First oral antiviral for Covid-19 approved by MHRA

Molnupiravir reduces risk of hospitalisation or death for at-risk adults with mild to moderate Covid-19 by 50 per cent.

04 Nov 2021

Change privacy settings